Abstract
Subarachnoid hemorrhage (SAH) is a hemorrhagic cerebrovascular disease with an extremely poor prognosis. The molecular mechanism and biomarkers involved in neurological outcome after SAH still need to be explored. This study assessed the microRNA expression characteristics of SAH patients with different neurological outcomes by meta-analysis. Public databases were searched from database inception until December 2022. The study reported that microRNA expression data in SAH patients with different neurological outcomes were included in the analysis. The differential expression of miRNAs was evaluated by meta-analysis. Overrepresentation analysis was performed for the targeted genes of significant miRNAs. The XGBoost algorithm was used to assess the predictive ability for neurological outcomes with clinical characteristics and significantly expressed miRNAs. Seven studies were finally included in the meta-analysis. The results showed that the levels of miR-152-3p (SMD: − 0.230; 95% CI − 0.389, − 0.070; padj = 0.041), miR-221-3p (SMD: − 0.286; 95% CI − 0.446, − 0.127; padj = 0.007), and miR-34a-5p (SMD: − 0.227; 95% CI − 0.386, − 0.067; padj = 0.041) were significantly lower in SAH patients with good neurological outcomes than in those with poor neurological outcomes. The PI3K-AKT signaling pathway may have an important role in neurological recovery after SAH. Based on the XGBoost algorithm, the neurological outcome could be accurately predicted with clinical characteristics plus the three miRNAs. The expression levels of miR-152-3p, miR-221-3p, and miR-34a-5p were significantly lower in patients with good neurological outcomes than in those with poor outcomes. These miRNAs can serve as potential predictive biomarkers for neurological outcomes.
Graphical Abstract
The molecular mechanism and biomarkers involved in neurological outcome after SAH still need to be explored. Our study analyzed microRNA expression characteristics of SAH patients with different neurological outcomes by meta-analysis. After analyze studies reporting the microRNA expression data in SAH patients with different neurological outcomes, results show that the levels of miR-152-3p, miR-221-3p, and miR-34a-5p were significantly lower in SAH patients with good neurological outcomes than in those with poor neurological outcomes. The PI3K-AKT signaling pathway may have an important role in neurological recovery after SAH. Based on the XGBoost algorithm, the neurological outcome could be accurately predicted with clinical characteristics plus the three miRNAs.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analysed during the current study are not publicly available but are available from the corresponding author on reasonable request.
References
Annoni F, Moro F, Caruso E et al (2022) Angiotensin-(1–7) as a potential therapeutic strategy for delayed cerebral ischemia in subarachnoid hemorrhage. Front Immunol 13:841692. https://doi.org/10.3389/fimmu.2022.841692
Bache S, Rasmussen R, Rossing M et al (2017) MicroRNA changes in cerebrospinal fluid after subarachnoid hemorrhage. Stroke 48:2391–2398. https://doi.org/10.1161/STROKEAHA.117.017804
Bache S, Rasmussen R, Wolcott Z et al (2020) Elevated miR-9 in cerebrospinal fluid is associated with poor functional outcome after subarachnoid hemorrhage. Transl Stroke Res 11:1243–1252. https://doi.org/10.1007/s12975-020-00793-1
Chen M, Zhang Q, Xiue W (2020) Correlation of miR-210 and TLR4 expression in peripheral blood of patients with aneurysmal subarachnoid hemorrhage and its clinical significance. J Mol Diagn Ther 12:1665–1669
Chen R, Wen D, Xiao A et al (2022b) Clinical characteristics of intracranial aneurysms in elderly patents over 70 years old: a retrospective observational study. BMC Neurol 22:255. https://doi.org/10.1186/s12883-022-02786-z
Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system. https://doi.org/10.1145/2939672.2939785
Chen F, Chen J, Lin H (2022a) Expression level and significance of miR-27a in patients with aneurysmal subarachnoid hemorrhage after interventional treatment. J Navy Med 43
Chou SH, Macdonald RL, Keller E, Unruptured Intracranial A, Investigators SCP (2019) Biospecimens and molecular and cellular biomarkers in aneurysmal subarachnoid hemorrhage studies: common data elements and standard reporting recommendations. Neurocrit Care 30:46–59. https://doi.org/10.1007/s12028-019-00725-4
Ghasempour E, Hesami S, Movahed E, Keshel SH, Doroudian M (2022) Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors. Stem Cell Res Ther 13:527. https://doi.org/10.1186/s13287-022-03212-4
Inzaghi E, Kistner A, Germani D et al (2020) A prospective case-control study on miRNA circulating levels in subjects born small for gestational age (SGA) evaluated from childhood into young adulthood. PLoS ONE 15:e0228075. https://doi.org/10.1371/journal.pone.0228075
Jiang Y, Gai Y, Long Y et al (2020) Application and evaluation of [(99m)Tc]-labeled peptide nucleic acid targeting microRNA-155 in breast cancer imaging. Mol Imaging 19:1536012120916124. https://doi.org/10.1177/1536012120916124
Jin J, Duan J, Du L et al (2022) Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): relevant signaling pathways and therapeutic strategies. Front Immunol 13:1027756. https://doi.org/10.3389/fimmu.2022.1027756
Lai NS, Zhang JQ, Qin FY et al (2017) Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage. Biosci Rep. https://doi.org/10.1042/BSR20160480
Liu D, Tang Y, Zhang Q (2021) Admission hyperglycemia predicts long-term mortality in critically ill patients with subarachnoid hemorrhage: a retrospective analysis of the MIMIC-III database. Front Neurol 12:678998. https://doi.org/10.3389/fneur.2021.678998
Ozansoy M, Mikati H, Velioglu HA, Yulug B (2023) Exosomes: A missing link between chronic systemic inflammation and Alzheimer’s disease? Biomed Pharmacother 159:114161. https://doi.org/10.1016/j.biopha.2022.114161
Pedrosa L, Hoyos J, Reyes L et al (2022) MicroRNA cerebrospinal fluid profile during the early brain injury period as a biomarker in subarachnoid hemorrhage patients. Front Cell Neurosci 16:1016814. https://doi.org/10.3389/fncel.2022.1016814
Song J, Wang J, Liu K et al (2022) The role of microRNAs in erectile dysfunction: from pathogenesis to therapeutic potential. Front Endocrinol 13:1034043. https://doi.org/10.3389/fendo.2022.1034043
Sticht C, De La Torre C, Parveen A, Gretz N (2018) miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE 13:e0206239. https://doi.org/10.1371/journal.pone.0206239
Ten Brinck MFM, Shimanskaya VE, Aquarius R et al (2022) Outcomes after flow diverter treatment in subarachnoid hemorrhage: a meta-analysis and development of a clinical prediction model (OUTFLOW). Brain Sci. https://doi.org/10.3390/brainsci12030394
Thind A, Wilson C (2016) Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles 5:31292. https://doi.org/10.3402/jev.v5.31292
Tian Q, Guo Y, Feng S et al (2022) Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway. J Neuroinflamm 19:312. https://doi.org/10.1186/s12974-022-02676-8
Wang ZY, Wen ZJ, Xu HM, Zhang Y, Zhang YF (2022) Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications. Front Mol Neurosci 15:1004221. https://doi.org/10.3389/fnmol.2022.1004221
Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2:100141. https://doi.org/10.1016/j.xinn.2021.100141
Zaiou M (2020) The emerging role and promise of circular RNAs in obesity and related metabolic disorders. Cells 9:1473. https://doi.org/10.3390/cells9061473
Zhao C, Tu S, Xue B, Luo C, Zhou X (2022) The level and significance of miR-193b-3p in patients with aneurysmal subarachnoid hemorrhage after hyperbaric oxygen treatment. Chin J Naut Med Hyperb Med 29
Zheng L, Zhang X, Liu L, Pu Y (2022) Altered Expression of specific microRNAs in plasma of aneurysmal subarachnoid hemorrhage patients. Front Neurol 13:842888. https://doi.org/10.3389/fneur.2022.842888
Zhu Q, Enkhjargal B, Huang L et al (2018) Aggf1 attenuates neuroinflammation and BBB disruption via PI3K/Akt/NF-kappaB pathway after subarachnoid hemorrhage in rats. J Neuroinflamm 15:178. https://doi.org/10.1186/s12974-018-1211-8
Funding
This work was supported by Appropriate Technology Extension Project of the Health and Health of the Autonomous Region in 2021(Clinician-led application and promotion of bedside intensive ultrasound technology) [SYTG-202172].
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by AA, BL and YC. The first draft of the manuscript was written by ZY and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethics Approval
This study was performed in line with the principles of the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, J., Liu, W., Anniwaer, A. et al. The Role of MicroRNAs in Predicting the Neurological Outcome of Patients with Subarachnoid Hemorrhage: A Meta-analysis. Cell Mol Neurobiol 43, 2883–2893 (2023). https://doi.org/10.1007/s10571-023-01327-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-023-01327-7